Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-citrinin | multiple interactions | ISO | MIR449A (Homo sapiens) | 6480464 | [Citrinin co-treated with ochratoxin A] results in increased expression of MIR449A mRNA | CTD | PMID:30428381 | 17beta-estradiol | multiple interactions | ISO | MIR449A (Homo sapiens) | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of MIR449A mRNA | CTD | PMID:22950660 | 2-methoxyethanol | decreases expression | ISO | Mir449a (Rattus norvegicus) | 6480464 | methyl cellosolve results in decreased expression of MIR449A mRNA | CTD | PMID:22008535 | 3-methylcholanthrene | multiple interactions | EXP | | 6480464 | [Methylcholanthrene co-treated with Nanotubes and Carbon] results in decreased expression of MIR449A mRNA | CTD | PMID:25926378 | atrazine | increases expression | ISO | Mir449a (Rattus norvegicus) | 6480464 | Atrazine results in increased expression of MIR449A mRNA | CTD | PMID:31185338 | atrazine | decreases expression | ISO | Mir449a (Rattus norvegicus) | 6480464 | Atrazine results in decreased expression of MIR449A mRNA | CTD | PMID:36841081 | bifenthrin | decreases expression | EXP | | 6480464 | bifenthrin results in decreased expression of MIR449A mRNA | CTD | PMID:32408700 | bis(2-chloroethyl) sulfide | increases expression | EXP | | 6480464 | Mustard Gas results in increased expression of MIR449A mRNA | CTD | PMID:26456178 | bisphenol A | increases methylation | ISO | Mir449a (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of MIR449A gene | CTD | PMID:28505145 | bleomycin A2 | affects expression | ISO | Mir449a (Rattus norvegicus) | 6480464 | Bleomycin affects the expression of MIR449A mRNA | CTD | PMID:25933445 | buta-1,3-diene | increases expression | EXP | | 6480464 | 1 and 3-butadiene results in increased expression of MIR449A mRNA | CTD | PMID:29038090 | cadmium dichloride | increases expression | ISO | Mir449a (Rattus norvegicus) | 6480464 | Cadmium Chloride results in increased expression of MIR449A mRNA | CTD | PMID:24462979 | cannabidiol | increases expression | EXP | | 6480464 | Cannabidiol results in increased expression of MIR449A mRNA | CTD | PMID:30742662 | cannabidiol | multiple interactions | EXP | | 6480464 | [lipopolysaccharide and E coli O55-B5 co-treated with Cannabidiol] results in increased expression of MIR449A mRNA | CTD | PMID:30742662 | carbon nanotube | multiple interactions | EXP | | 6480464 | [Methylcholanthrene co-treated with Nanotubes and Carbon] results in decreased expression of MIR449A mRNA | CTD | PMID:25926378 | dexamethasone | decreases expression | ISO | Mir449a (Rattus norvegicus) | 6480464 | Dexamethasone results in decreased expression of MIR449A mRNA | CTD | PMID:33619658 | irinotecan | increases expression | ISO | MIR449A (Homo sapiens) | 6480464 | Irinotecan results in increased expression of MIR449A mRNA | CTD | PMID:22898888 | lead(0) | increases expression | ISO | Mir449a (Rattus norvegicus) | 6480464 | Lead results in increased expression of MIR449A mRNA | CTD | PMID:24960059 | mechlorethamine | increases expression | ISO | Mir449a (Rattus norvegicus) | 6480464 | Mechlorethamine results in increased expression of MIR449A mRNA | CTD | PMID:33971176 | methimazole | multiple interactions | EXP | | 6480464 | [Methimazole co-treated with Buthionine Sulfoximine] results in decreased expression of MIR449A mRNA and [Methimazole co-treated with Buthionine Sulfoximine] results in increased expression of MIR449A mRNA | CTD | PMID:27421576 | Monobutylphthalate | increases expression | ISO | Mir449a (Rattus norvegicus) | 6480464 | monobutyl phthalate results in increased expression of MIR449A mRNA | CTD | PMID:29162477 | ochratoxin A | increases expression | ISO | MIR449A (Homo sapiens) | 6480464 | ochratoxin A results in increased expression of MIR449A mRNA | CTD | PMID:30428381 | ochratoxin A | multiple interactions | ISO | MIR449A (Homo sapiens) | 6480464 | [Citrinin co-treated with ochratoxin A] results in increased expression of MIR449A mRNA | CTD | PMID:30428381 | paracetamol | multiple interactions | ISO | MIR449A (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of and results in increased secretion of MIR449A mRNA | CTD | PMID:29067470 | paracetamol | decreases response to substance | ISO | MIR449A (Homo sapiens) | 6480464 | MIR449A mRNA results in decreased susceptibility to Acetaminophen | CTD | PMID:29067470 | progesterone | multiple interactions | ISO | MIR449A (Homo sapiens) | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of MIR449A mRNA | CTD | PMID:22950660 | progesterone | decreases expression | ISO | MIR449A (Homo sapiens) | 6480464 | Progesterone results in decreased expression of MIR449A mRNA | CTD | PMID:22950660 | S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | EXP | | 6480464 | [Methimazole co-treated with Buthionine Sulfoximine] results in decreased expression of MIR449A mRNA and [Methimazole co-treated with Buthionine Sulfoximine] results in increased expression of MIR449A mRNA | CTD | PMID:27421576 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of MIR449A mRNA | CTD | PMID:32068019 | sodium fluoride | increases expression | EXP | | 6480464 | Sodium Fluoride results in increased expression of MIR449A mRNA | CTD | PMID:29127033 | sodium fluoride | increases expression | ISO | Mir449a (Rattus norvegicus) | 6480464 | Sodium Fluoride results in increased expression of MIR449A | CTD | PMID:37121298 | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of MIR449A mRNA | CTD | PMID:21259345 | tributyl phosphate | decreases expression | EXP | | 6480464 | tributyl phosphate results in decreased expression of MIR449A mRNA | CTD | PMID:32105654 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of MIR449A mRNA | CTD | PMID:24896083 | |